FDA Revises Invokana Label to Include Bone Fracture Risk

September 10th, 2015- The FDA has strengthened the warning for the type 2 diabetes drug Invokana related to the increased risk of bone fractures and added new information about decreased bone...

Canadian Study Reveals Further Surgery for Mesh Patients

September 10, 2015- According to a new study, Canadian women  who received vaginal mesh to treat incontinence had a one in 30 chance they would need to have the mesh removed...

What to Expect at the Essure FDA Panel

San Diego, CA September 9, 2015-- On September 24 the FDA will convene to review and evaluate data concerning the safety and effectiveness of Essure, a permanent birth control device...

What to Expect at the Essure FDA Panel

San Diego, CA September 9, 2015-- On September 24 the FDA will convene to review and evaluate data concerning the safety and effectiveness of Essure, a permanent birth control device...

C.R. Bard Gives Little Weight to IVC Complications

San Diego, CA September 4, 2015 -- C.R. Bard is facing heat over it's blood-clot device, the IVC Filter. Reports have surfaced that IVC filters caused serious injuries, and in...

What are the Essure Complications?

San Diego, CA September 3, 2015 -- Women, like Kama Sales, were attracted to Essure because of the marketing that it’s a simple procedure with a quick recovery. Kama Sales...

Essure Problems – Essure Issues

September 1, 2015 -- San Diego, CA Essure, the permanent birth control marketed to women, is stirring up controversy about its problems. While it’s marketed as a simple, quick solution...

Janssen Accused of Hiding Risperdal Autism Data

Janssen Pharmaceuticals, the manufacturer of Risperdal, which is widely used in autistic children, willingly withdrew data on its side effects from a 2003 study, according to evidence presented in a...

New Developments in Xarelto Side Effects Research

San Diego, CA -- August 27, 2015 Since it's introduction, Xarelto's run on the blood thinner market has been riddled with several lawsuits alleging that the drug causes serious side...

Sanofi and Bristol-Myers Catch Break in Plavix Case

San Diego, CA -- August 25, 2015 Unfortunately, Bristol-Myers Squibb and Sanofi scored a victory in a False Claims Act marketing case over their blood thinner, Plavix.  A federal judge...